ITMCTR2200006748尚未招募未知
Evaluation of the efficacy of Yinqiao Baiyi Decoction for asymptomatic patients infected with COVID-19
The First Affiliated Hospital to Henan University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •? Asymptomatic patients with COVID-19;
- •? Age 18-80 years old;
- •? Voluntarily accept treatment and sign informed consent.
排除标准
- •? delirious, consciousness disorder, dementia, all kinds of mental patients;
- •? Pregnant and lactating women;
- •? Patients with active pulmonary tuberculosis, pulmonary abscess and chronic respiratory failure;
- •? Patients with tumor;
- •? Patients with severe liver and kidney diseases;
- •? patients with severe cardiovascular and cerebrovascular diseases;
- •? those who are taking part in clinical trials of other drugs and are known to be allergic to the treatment drugs.
研究者
相似试验
尚未招募
不适用
Evaluation of the efficacy of Yinqiao Baiyi Decoction in treating mild patients with COVID-19ITMCTR2200006746The First Affiliated Hospital to Henan University of Chinese Medicine
招募中
不适用
Effectiveness of Yiqi Bushen Lixue Yangtai decoction on Th17/Treg cell balance in unexplained recurrent spontaneous abortioITMCTR2100005086Obstetrics and Gynecology Hospital of Fudan University
招募中
1 期
Efficacy of Buzhong Yiqi Decoction in the Treatment of Ocular Myopathy Myasthenia Gravis (MG) Patients with Spleen and Kidney Deficiency Type: a Randomized Controlled TrialOcular myasthenia gravisITMCTR2200005637Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University
招募中
不适用
The curative effect evaluation for Yi-Qi Yang-Yin Huo-Xue prescription in treatment of the high risk population of hepatitis B cirrhosis with chronic kidney injurychronic kidney diseaseITMCTR1900002717Beijing Ditan Hospital Affiliated to Capital Medical University
招募中
1 期
A clinical study on the efficacy of Yiqi Huayu Jiedu decoction for reducing the risk of postoperative recurrence and metastasis of gastric cancer Protocol for a multicenter, randomized, double-blind, placebo-controlled trialgastric cancerITMCTR2100004250Department of Oncology, Jiangsu Province Hospital of Chinese Medicine